First pass results of mechanical thrombectomy with two-drop zone NeVa TM device

Occlusive thrombi in acute ischemic stroke can be in various types which limits the success of the thrombectomy. The NeVa (Vesalio, Nashville, Tennessee) thrombectomy device was originally designed for all types of clot. Our aim was to evaluate the efficacy and safety of the NeVa device for mechanic...

Full description

Saved in:
Bibliographic Details
Published in:Interventional neuroradiology 2024-08, Vol.30 (4), p.458-462
Main Authors: Bajrami, Arsida, Ertugrul, Ozgur, Senadim, Songul, Erdem, Eren, Baltacioglu, Feyyaz, Geyik, Serdar
Format: Article
Language:English
Subjects:
Aged
Cerebral Angiography
Equipment Design
Female
Humans
Ischemic Stroke - surgery
Male
Middle Aged
Retrospective Studies
Thrombectomy - instrumentation
Thrombectomy - methods
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Occlusive thrombi in acute ischemic stroke can be in various types which limits the success of the thrombectomy. The NeVa (Vesalio, Nashville, Tennessee) thrombectomy device was originally designed for all types of clot. Our aim was to evaluate the efficacy and safety of the NeVa device for mechanical thrombectomy. Retrospective review of prospectively collected mechanical thrombectomy database revealed 145 patients who had fullfilled the inclusion criteria. The data collected includes clinical patient characteristics, procedural measures, timestamp at each stage, and patient outcome. IV thrombolytics application, pre and post-intervention imaging findings, device related adverse event and any type of intracranial hemorrhage were recorded. There was female pre-dominance (54.5%). Median presenting national institutes of health stroke scale (NIHSS) was 16 (IQR, 3-32). 88 MCA-m1 (60,6%), 43 ICA-tip (29,6%), 11 MCA-m2 (7,5%), 2 ACA (1,4%) and 1 basilar (0,7%) occlusions were underwent for mechanical thrombectomy. Median procedure time was 25 min (IQR, 7-136). First-pass reperfusion scores were mTICI 0-2a 22.7%, mTICI 2b 23.4%, mTICI 2c 17.9% and mTICI 3 35.9%. Mean number of pass was 1,84 ± 1,14. Final mTICI 2b-3 score was 97.9% and TICI2c-3 score was 87.6%. No device related adverse event occurred. The mean 24-h NIHSS score was 6 (IQR 0-33). In conclusion, the NeVa thrombectomy device offers a high rate of first-pass success along with favorable safety profile. Larger series and multi-center studies are needed for further investigation.
ISSN:1591-0199
2385-2011
DOI:10.1177/15910199221135309